Octreotide in the treatment of acromegaly – the possibilities of high-dose therapy
Octreotide is a first-generation somatostatin analog that has been used for 40 years for the medical treatment of acromegaly, both after neurosurgical intervention and as first-line treatment. The frequency of biochemical control against the background of extended-acting octreotide varies from 25 to...
Main Author: | I. A. Ilovayskaya |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2022-06-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/6942 |
Similar Items
-
Adherence to somatostatin analog therapy for acromegaly
by: I. A. Ilovayskaya
Published: (2021-05-01) -
Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement
by: Sang Ouk Chin, et al.
Published: (2019-03-01) -
New opportunities for secondary drug therapy of acromegaly
by: V. S. Pronin, et al.
Published: (2020-05-01) -
Novel Somatostatin Receptor Ligands Therapies for Acromegaly
by: Rosa Maria Paragliola, et al.
Published: (2018-03-01) -
COMPARATIVE PHARMACOECONOMIC ANALYSIS OF LONG-ACTING LANREOTIDE USED IN ACROMEGALY THERAPY WITHIN CONDITIONS OF THE RUSSIAN FEDERATION HEALTH CARE SYSTEM
by: I. S. Krysanov, et al.
Published: (2022-05-01)